The invention relates to compounds of formula: ##STR00001## These compounds show affinity for the bradykinin receptors with selectivity towards the B.sub.1 receptors; they may be used for the preparation of medicinal products intended for treating or preventing inflammation pathologies and persistent or chronic inflammatory diseases.